Table 2.
Limited quality single-shot SSFP vs. breath-hold GRE studies in non-ICD patients
| Non-ICD patients | ||||
|---|---|---|---|---|
| ss-SSFP LGE | Breath-hold GRE LGE | p-value | Selected Study (ss-SSFP or bh-GRE LGE) | |
| Motion limited | ||||
| #Studies classified | 18 | 14 | 0.19 | 18 (11 ss-SSFP*, 7 GRE LGE**) |
| #Limited studies (%) | 2/18 (11%) | 5/14 (36%) | 1/18 (5.6%) | |
| Contrast limited | ||||
| #Studies classified | 18 | 10 | 0.37 | 18 (11 ss-SSFP*, 7 GRE LGE**) |
| #Limited studies (%) | 5/18 (28%) | 1/10 (10%) | 5/18 (28%) | |
| Overall limited | ||||
| #Studies classified | 18 | 14 | 0.46 | 18 (11 ss-SSFP*, 7 GRE LGE**) |
| #Limited studies (%) | 5/18 (28%) | 6/14 (43%) | 5/18 (28%) | |
(*) ss-SSFP was selected because of improved motion quality in 7 of 11 cases. In the remaining 4 of 11 cases, ss-SSFP was selected because GRE LGE was not performed due to unrelated protocol development
(**) The breath-hold GRE LGE was selected if it had and equal or better quality than ss-SSFP LGE